Status: current, Primitive. Date: 31-Jul 2007. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2661566017 | Darifenacin hydrobromide (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 2675147016 | Darifenacin hydrobromide | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Darifenacin hydrobromide | Is a | Antispasmodic | true | Inferred relationship | Some | ||
| Darifenacin hydrobromide | Is a | Darifenacin | false | Inferred relationship | Some | ||
| Darifenacin hydrobromide | Has disposition | Muscarinic receptor antagonist | true | Inferred relationship | Some | ||
| Darifenacin hydrobromide | Is modification of | Darifenacin | true | Inferred relationship | Some | ||
| Darifenacin hydrobromide | Is a | Pyrrolidine | true | Inferred relationship | Some | ||
| Darifenacin hydrobromide | Is a | Benzofuran | true | Inferred relationship | Some | ||
| Darifenacin hydrobromide | Is a | Muscarinic receptor antagonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Darifenacin 7.5mg m/r tablet | Has active ingredient | False | Darifenacin hydrobromide | Inferred relationship | Some | |
| Darifenacin 15mg m/r tablet | Has active ingredient | False | Darifenacin hydrobromide | Inferred relationship | Some | |
| Darifenacin (as darifenacin hydrobromide) 15 mg prolonged-release oral tablet | Has precise active ingredient | True | Darifenacin hydrobromide | Inferred relationship | Some | 1 |
| Darifenacin (as darifenacin hydrobromide) 7.5 mg prolonged-release oral tablet | Has precise active ingredient | True | Darifenacin hydrobromide | Inferred relationship | Some | 1 |
Reference Sets
Substance foundation reference set
FHIR